설사 증상의 돼지 분변에서 분리된 용혈성 대장균의 항생제 내성과 독소의 인체로부터 분리된 균주로의 전이

Transfer of Genes for Antimicrobial Resistance and Toxin of Hemolytic Escherichia coli Isolated from Feces of Pig Suffering Diarrhea to Human Isolates

  • 이계남 (서울여자대학교 생물학과 항생제내성균주은행) ;
  • 정병열 (수의과학검역원 동물약품과) ;
  • 이연희 (서울여자대학교 생물학과 항생제내성균주은행)
  • Lee Kyenam (Department of Biology and Culture Collection of Antimicrobial Resistant Microbes, Seoul Women's University) ;
  • Jung Byeong Yeal (National Veterinary Research and Quarantine) ;
  • Lee Yeonhee (Department of Biology and Culture Collection of Antimicrobial Resistant Microbes, Seoul Women's University)
  • 발행 : 2004.12.01

초록

1997년과 1998년 사이에 설사 증상을 보이는 돼지의 분변으로부터 총56균주의 Escherichia coli를 분리하여 이중 용혈성을 나타내는 38균주의 항생제 내성과 독소 생산능을 확인하였다. 항생제 한천 희석법으로 최소억제농도(minimal inhibitory concentration)를 측정한 결과 36균주$(94.7\%)$가 tetracycline에 대해 내성을 나타내었고, 27주$(71.0\%)$는 ampicillin에 내성, 26균주$(68.4\%)$는 chloramphenicol에 내성, 그리고 21균주$(55.2\%)$는 tri-methoprim에 내성을 나타내었으나, aztreonam, amikacin, norfloxacin에 내성을 나타낸 균주는 발견되지 않았다. 이중 4가지 이상의 항생제에 대해 내성을 가지는 다제내성(multiple drug resistance, MDR)을 보인 균주는 총 38 균주 중 21균주$(55.3\%)$였다. 또한 이중 디스크 시험법(Double Disk Synergy Test)을 수행한 결과 extended spectrum $\beta-lactamase$를 생산하는 균주는 없는 것으로 나타났다. 이들 중 가장 많은 수의 균주가 내열성 독소$(ST,89.5\%)$를 생산하였고, 다음으로 베로 독소(VT와 VTe, 각각$47.4\%$)와 이열성 독소$(LT,31.6\%)$를 생산하는 것으로 나타났다. 이 중에서 8균주$(21.0\%)$는 57만을 생산하였던 반면에 12균주$(31.6\%)$는 LT와 ST를 동시에 생산하였고, 13균주$(34.2\%)$는 ST, VT, VTe를 동시에 생산하였으며, 5균주$(13.2\%)$는 VT와 VTe를 동시에 생산하는 것으로 나타났다. 그러나 네 가지 독소를 동시에 생산하는 균주는 없었다. 또한 이 균주들은 매우 다양한 혈청형(serotype)을 가지고 있음이 확인되었다. 사람에 직접적인 유해성을 가지고 있는 지 확인하기 위해 사람 방광 유래의 T-24세포와 장내 표피 유래의 Caco-2세포에 대한 부착능을 시험하였을 때, 16균주$(42.1\%)$가 T-24방광 세포에, 그리고 17균주$(44.7\%)$가 Caco-2장세포에 대해 강한 부착능을 나타내었다. 특히 11균주$(28.9\%)$는 두 세포 모두에 강한 부착능을 가지고 있었다. Filter mating method를 수행하여 이들 균주들의 독소 생산 유전자와 항생제 내성 유전자가 사람에서 분리된 균주로 전달되는 것을 확인할 수 있었다. 본 실험의 결과는 설사 중상을 나타내는 돼지로부터 분리된 용혈성 E. coli의 독성과 세포 부착능력, 그리고 항생제 내성간의 상호 연관성을 보여주지 않았으나 동물 분리 세균의 항생제 내성과 독소 생산 능력이 유전자 전달을 통해서 뿐만 아니라 세균의 직접 접촉에 의해서도 인체로 전달될 수 있는 것을 보여주는 것이다.

Between 1997 and 1998 in Korea, 56 isolates of Escherichia coli were obtained from pig suffering diarrhea. Among those, 38 isolates that showed the hemolytic activity, antimicrobial resistance, and toxin production were studied. Among 38 isolates, thirty-six isolates $(94.7\%)$ were resistant to tetracycline, 27 isolates $(71.0\%)$ were resistant to ampicillin, 26 isolates $(68.4\%)$ were resistant to chloramphenicol, and 21 isolates $(55.2\%)$ were resistant to trimethoprim, while none was resistant to aztreonam, amikacin, and norfloxacin. Among these iso­lates, 21 isolates $(55.3\%)$ were multiple drug resistant to at least four different class antimicrobial agents. Extended spectrum $\beta-lactamase$ producing isolates were not detected in the double disk synergy test. In these hemolytic Escherichia coli, heat-stable enterotoxin $(89.5\%)$ was the most prevalent toxin, followed by vero­toxins $(47.4\%),$ and then heat-labile enterotoxin $(31.6\%).$ Except 8 isolates $(21.0\%)$ which produced ST only, 12 isolates $(31.6\%)$ produced ST and LT, 13 isolates $(34.2\%)$ produced ST, VT, and VTe, and 5 isolates $(13.2\%)$ produced VT and VTe. However, none produced all 4 types of toxin, simultaneously. The predominant serotype could not be determined by the agglutination method. Sixteen isolates $(42.1\%)$ were strongly adhered to T-24 bladder cell and 17 isolates $(44.7\%)$ were to Caco-2 intestinal cell. Especially, 11 strains $(28.9\%)$ were evaluated as strongly adhesive to both T-24 cells and Caco-2 cells. Genes for toxin and the antimicrobial resistance were transferred to clinical isolates of Escherichia coli from human urine by the filter mating method. Results suggest the possibility that antimicrobial resistance and toxin can be transferred from animals to humans by direct con­tact of resistant bacteria as well as gene transfer, although there was no correlation between toxin production, adherent activity, and antimicrobial resistance among hemolytic E. coli isolated from pig suffering diarrhea.

키워드

참고문헌

  1. Agbodaze, D. 1999. Verocytotoxins (Shiga-like toxins) produced by Escherichia coli: a minireview of their classification, clinical presentations and management of a heterogeneous family of cytotoxins. Comp. Immunol. Microbiol. Infect. Dis. 22, 221-230
  2. Bischoff, K.M., D.G. White, P.F. McDermott, S. Zhao, S. Gaines, J.J. Maurer, and D.J. Nisbet. 2002. Characterization of chloramphenicol resistance in beta-hemolytic Escherichia coli associated with diarrhea in neonatal swine. J. Clin. Microbiol. 40, 389-394
  3. Blanco, M., J.E. Blanco, E.A. Gonzalez, A. Mora, W. Jansen, T.A. Gomes, L.F. Zerbini, T. Yano, A.F. de Castro, and J. Blanco. 1997. Genes coding for enterotoxins and verotoxins in porcine Escherichia coli strains belonging to different O:K:H serotypes: relationship with toxic phenotypes. J. Clin. Microbiol. 35, 2958-2963
  4. Blanco, J.E., M. Blanco, A. Mora, and J. Blanco. 1997. Production of toxins (enterotoxins, verotoxins, and necrotoxins) and colicins by Escherichia coli strains isolated from septicemic and healthy chickens: Relationship with in vivo pathogenicity. J. Clin. Microbiol. 35, 2953-2957
  5. Blanco, M., J.E. Blanco, A. Mora, G. Dahbi, M.P. Alonso, E.A. Gonzalez, M.I. Bernardez, and J. Blanco. 2004. Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from cattle in Spain and identification of a new intimin variant gene (eae-xi). J. Clin. Microbiol. 42, 645- 651
  6. Celemin, C., P. Rubio, P. Echeverria, and S. Suarez. 1995. Gene toxin patterns of Escherichia coli isolated from diseased and healthy piglets. Vet. Microbiol. 45, 121-127
  7. Cheng, E., L. Cardenas-Freytag, and J.D. Clements. 1999. The role of cAMP in mucosal adjuvanticity of Escherichia coli heatlabile enterotoxin (LT). Vaccine 20, 38-49
  8. Choi, C., W. Cho, H. Chung, T. Jung, J. Kim, and C. Chae. 2001. Prevalence of the enteroaggregative Escherichia coli heat-stable enterotoxin 1 (EAST1) gene in isolates in weaned pigs with diarrhea and/or edema disease. Vet. Microbiol. 81, 65-71
  9. Choi, C., H.J. Ham, D. Kwon, J. Kim, D.S. Cheon, K. Min, W.S. Cho, H.K. Chung, T. Jung, K. Jung, and C. Chae. 2002. Antimicrobial susceptibility of pathogenic Escherichia coli isolated from pigs in Korea. J. Vet. Med. Sci. 64, 71-73
  10. Clarke, S.C. 2001. Diarrhoeagenic Escherichia coli- an emerging problem? Diagn. Microbiol. Infect. Dis. 41, 93-98
  11. Cobbold, R. and P. Desmarchelier. 2002. Horizontal transmission of Shiga toxin-producing Escherichia coli within groups of dairy calves. Appl. Environ. Microbiol. 68, 4148-4152
  12. Friedrich, A.W., J. Borell, M. Bielaszewska, A. Fruth, H. Tschape, and H. Karch. 2003. Shiga toxin 1c-producing Escherichia coli strains: phenotypic and genetic characterization and association with human disease. J. Clin. Microbiol. 41, 2448-2453
  13. Frydendahl, K. 2002. Prevalence of serogroups and virulence genes in Escherichia coli associated with postweaning diarrhoea and edema disease in pigs and a comparison of diagnostic approaches. Vet. Microbiol. 85, 169-182
  14. Garabal, J.I., E.A. Gonzalez, F. Vazquez, J. Blanco, and M, Blanco. 1995. Toxigenic Escherichia coli in Spanish piggeries from 1986 to 1991. Vet. Microbiol. 47, 17-25
  15. Karmali, M.A. 1989. Infection by verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 2, 15-38
  16. Laohachai, K.N., R. Bahadi, M.B. Hardo, P.G. Hardo, and J.I. Kourie. 2003. The role of bacterial and non-bacterial toxins in the induction of changes in membrane transport: implications for diarrhea. Toxicon. 42, 687-707
  17. Lee, S.H., J.Y. Kim, S.H. Shin, Y.J. An, Y.W. Choi, Y.C. Jung, H.I. Jung, E.S. Sohn, S.H. Jeong, and K.J. Lee. 2003. Dissemination of SHV-12 and characterization of new AmpC-type beta-lactamase genes among clinical isolates of Enterobacter species in Korea. J. Clin. Microbiol. 41, 2477-2482
  18. Maynard, C., J.M. Fairbrother, S. Bekal, F. Sanschagrin, R.C. Levesque, R. Brousseau, L. Masson, S. Lariviere, and J. Harel. 2003. Antimicrobial resistance genes in enterotoxigenic Escherichia coli O149:K91 isolates obtained over a 23-year period from pigs. Antimicrob. Agents Chemother. 47, 3214-3221
  19. Merritt, E.A. and W.G. Hol. 1995. AB5 toxins. Curr. Opin. Struct. Biol. 5, 165-171
  20. Montecucco, C., E. Papini, and G. Schiavo. 1994. Bacterial protein toxins penetrate cells via a four-step mechanism. FEBS Let. 346, 92-98
  21. Montecucco, C. 1998. Protein toxins and membrane transport. Curr. Opin. Cell Biol. 10, 530-536
  22. Nagano, K., K. Taguchi, T. Hara, S. Yokoyaa, K. Kawada, and H. Mori. 2003. Adhesion and colonization of enterohemorrhagic Escherichia coli O157:H7 in cecum of mice. Microbiol. Immunol. 47, 125-132
  23. Nair, G.B. and Y. Takeda. 1998. The heat-stable enterotoxins. Microbial Pathogenesis. 24, 123-131
  24. Nataro, J.P. and J.B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11, 142-201
  25. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved Standard-Fifth Edition. NCCLS
  26. Nelson, E.C. and B.G. Elisha. 1999. Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 43, 957-959
  27. O’Loughlin, E.V. and R.M. Robins-Browne. 2001. Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells. Microbes Infect. 3, 493-507
  28. Osek, J. 1999. Prevalence of virulence factors of Escherichia coli strains isolated from diarrheic and healthy piglets after weaning. Vet. Microbiol. 68, 209-217
  29. Osek, J. 2000. Virulence factors and genetic relatedness of Escherichia coli strains isolated from pigs with post-weaning diarrhea. Vet. Microbiol. 71, 211-222
  30. Pabst, W.L., M. Altwegg, C. Kind, S. Mirjanic, D. Hardegger, and D. Nadal. 2003. Prevalence of enteroaggregative Escherichia coli among children with and without diarrhea in Switzerland. J. Clin. Microbiol. 41, 2289-2293
  31. Pai, H., H.J. Lee, E.H. Choi, J. Kim, and G.A. Jacoby. 2001. Evolution of TEM-related extended-spectrum â-lactamases in Korea. Antimicrob. Agents Chemother. 45, 3651-3653
  32. Paton, J.C. and A.W. Paton. 1998. Pathogenesis and diagnosis of shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 11, 450-479
  33. Payne, C.J., M. Petrovic, R.J. Roberts, A. Paul, E. Linnane, M. Walker, D. Kerby, A. Burgess, R.M. Smith, T. Cheasty, G. Willshaw, and R.L. Salmon. 2003. Vero cytotoxin-producing Escherichia coli O157 gastroenteritis in farm visitors, North Wales. Emerg. Infect. Dis. 9, 526-530
  34. Peruski, L.F. Jr, B.A. Kay, R.A. El-Yazeed, S.H. El-Etr, A. Cravioto, T.F. Wierzba, M. Rao, N. El-Ghorab, H. Shaheen, S.B. Khalil, K. Kamal, M.O. Wasfy, A.M. Svennerholm, J.D. Clemens, and S.J. Savarino. 1999. Phenotypic diversity of enterotoxigenic Escherichia coli strains from a community-based study of pediatric diarrhea in periurban Egypt. J. Clin. Microbiol. 37, 2974-2978
  35. Qadri, F., S.K. Das, A.S. Faruque, G.J. Fuchs, M.J. Albert, R.B. Sack, and A.M. Svennerholm. 2000. Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. J. Clin. Microbiol. 38, 27-31
  36. Rappuoli, R., M. Pizza, G. Douce, and G. Dougan. 1999. Structure and mucosal adjuvanticity of cholera and Escherichia coli heatlabile enterotoxins. Immunol. Today 20, 493-500
  37. Sandvig, K. 2001. Shiga toxins. Toxicon. 39, 1629-1635
  38. Stacy-Phipps, S., J.J. Mecca, and J.B. Weiss. 1995. Multiplex PCR assay and simple preparation method for stool specimens detect enterotoxigenic Escherichia coli DNA during course of infection. J. Clin. Microbiol. 33, 1054-1059
  39. Vidal, R., M. Vidal, R. Lagos, M. Levine, and V. Prado. 2004. Multiplex PCR for diagnosis of enteric infections associated with diarrheagenic Escherichia coli. J. Clin. Microbiol. 42, 1787-1789
  40. Waddell, T.E., C.A. Lingwood, and C.L. Gyles. 1996. Interaction of verotoxin 2e with pig intestine. Infect. Immun. 64, 1714-1719